Irina Abécassis

543 total citations · 1 hit paper
7 papers, 371 citations indexed

About

Irina Abécassis is a scholar working on Molecular Biology, Oncology and Hematology. According to data from OpenAlex, Irina Abécassis has authored 7 papers receiving a total of 371 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 3 papers in Oncology and 3 papers in Hematology. Recurrent topics in Irina Abécassis's work include Acute Myeloid Leukemia Research (3 papers), Retinoids in leukemia and cellular processes (3 papers) and DNA Repair Mechanisms (1 paper). Irina Abécassis is often cited by papers focused on Acute Myeloid Leukemia Research (3 papers), Retinoids in leukemia and cellular processes (3 papers) and DNA Repair Mechanisms (1 paper). Irina Abécassis collaborates with scholars based in United States, France and Germany. Irina Abécassis's co-authors include A. Karniguian, michel schmid, Gérard Zalcman, Birgitta Olofsson, Tullia C. Bruno, Umamaheswar Duvvuri, Huda I. Atiya, Ryan J. Soose, Robert Lafyatis and Robert L. Ferris and has published in prestigious journals such as Nature Communications, Scientific Reports and Experimental Cell Research.

In The Last Decade

Irina Abécassis

7 papers receiving 370 citations

Hit Papers

B cell signatures and tertiary lymphoid structures contri... 2021 2026 2022 2024 2021 50 100 150 200

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Irina Abécassis United States 6 186 154 147 80 41 7 371
Yoshifumi Tomizuka Japan 6 332 1.8× 178 1.2× 134 0.9× 83 1.0× 23 0.6× 6 426
Purnima K. Wagh United States 9 136 0.7× 103 0.7× 286 1.9× 40 0.5× 38 0.9× 11 449
Eslam A. Elghonaimy Egypt 11 273 1.5× 130 0.8× 241 1.6× 103 1.3× 36 0.9× 18 511
Inge S. van Houdt Netherlands 7 183 1.0× 176 1.1× 130 0.9× 43 0.5× 21 0.5× 8 346
Megan N. Thobe United States 7 154 0.8× 122 0.8× 265 1.8× 39 0.5× 46 1.1× 11 444
Binh Phong United States 8 98 0.5× 246 1.6× 126 0.9× 40 0.5× 12 0.3× 11 364
Weihong Xu United States 10 96 0.5× 272 1.8× 266 1.8× 56 0.7× 28 0.7× 17 576
Jingtong Zhai China 10 169 0.9× 38 0.2× 110 0.7× 105 1.3× 75 1.8× 21 334
Berglind O. Einarsdottir Sweden 9 133 0.7× 98 0.6× 235 1.6× 125 1.6× 20 0.5× 13 395
S Ferjancic United Kingdom 2 180 1.0× 171 1.1× 130 0.9× 77 1.0× 39 1.0× 2 357

Countries citing papers authored by Irina Abécassis

Since Specialization
Citations

This map shows the geographic impact of Irina Abécassis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Irina Abécassis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Irina Abécassis more than expected).

Fields of papers citing papers by Irina Abécassis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Irina Abécassis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Irina Abécassis. The network helps show where Irina Abécassis may publish in the future.

Co-authorship network of co-authors of Irina Abécassis

This figure shows the co-authorship network connecting the top 25 collaborators of Irina Abécassis. A scholar is included among the top collaborators of Irina Abécassis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Irina Abécassis. Irina Abécassis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Ruffin, Ayana T., Anthony R. Cillo, Tracy Tabib, et al.. (2021). B cell signatures and tertiary lymphoid structures contribute to outcome in head and neck squamous cell carcinoma. Nature Communications. 12(1). 3349–3349. 230 indexed citations breakdown →
2.
Abécassis, Irina, Andrew J. Sedgewick, Marjorie Romkes, et al.. (2019). PARP1 rs1805407 Increases Sensitivity to PARP1 Inhibitors in Cancer Cells Suggesting an Improved Therapeutic Strategy. Scientific Reports. 9(1). 3309–3309. 22 indexed citations
3.
Abécassis, Irina, et al.. (2016). The leukemic oncoprotein NPM1-RARA inhibits TP53 activity. Leukemia & lymphoma. 57(8). 1933–1937. 2 indexed citations
4.
Abécassis, Irina, et al.. (2015). NPM-RAR binding to TRADD selectively inhibits caspase activation, while allowing activation of NFκB and JNK. Leukemia & lymphoma. 56(12). 3401–3406. 7 indexed citations
5.
Abécassis, Irina, et al.. (2013). Interaction with RXR is necessary for NPM-RAR-induced myeloid differentiation blockade. Leukemia Research. 37(12). 1704–1710. 7 indexed citations
6.
Abécassis, Irina, Johan Maes, Josette Hillion, et al.. (2007). Re-expression of DNA methylation-silenced CD44 gene in a resistant NB4 cell line: rescue of CD44-dependent cell death by cAMP. Leukemia. 22(3). 511–520. 14 indexed citations
7.
Abécassis, Irina, Birgitta Olofsson, michel schmid, Gérard Zalcman, & A. Karniguian. (2003). RhoA induces MMP-9 expression at CD44 lamellipodial focal complexes and promotes HMEC-1 cell invasion. Experimental Cell Research. 291(2). 363–376. 89 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026